ENDP Insider Trading
ENDP | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at ENDP provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2021-03-16 23:01 | 2021-03-15 | MONTAGUE WILLIAM P | Director | SELL | $8.68 | 9,033 | $78,406 | 97,104 | -8.5% |
| 2021-03-15 23:36 | 2021-03-15 | Cooke Shane | Director | SELL | $8.65 | 17,290 | $149,559 | 77,030 | -18.3% |
| 2019-09-18 00:23 | 2019-09-16 | KIMMEL ROGER H | Director | SELL | $4.09 | 55,000 | $224,950 | 80,000 | -40.7% |
| 2019-06-19 23:01 | 2019-06-17 | KIMMEL ROGER H | Director | SELL | $3.93 | 34,951 | $137,357 | 110,000 | -24.1% |
| 2018-12-11 00:07 | 2018-12-10 | MONTAGUE WILLIAM P | Director | SELL | $11.41 | 10,000 | $114,100 | 64,888 | -13.4% |
| 2018-11-17 00:03 | 2018-11-15 | Hutson Nancy J | Director | SELL | $12.83 | 10,000 | $128,300 | 49,970 | -16.7% |
| 2018-08-15 23:22 | 2018-08-14 | KIMMEL ROGER H | Director | SELL | $15.90 | 26,074 | $414,577 | 120,000 | -17.8% |
| 2017-11-18 00:03 | 2017-11-15 | KIMMEL ROGER H | Director | SELL | $6.90 | 9,134 | $63,025 | 136,140 | -6.3% |
| 2017-08-15 21:55 | 2017-08-15 | Maletta Matthew Joseph | Officer - EVP, Chief Legal Officer | BUY | $8.02 | 3,000 | $24,060 | 6,984 | +75.3% |
| 2017-08-15 21:15 | 2017-08-15 | Coleman Blaise | Officer - EVP, Chief Financial Officer | BUY | $7.89 | 6,500 | $51,285 | 13,729 | +89.9% |
| 2017-08-15 21:31 | 2017-08-14 | Campanelli Paul | Director, Officer - President, CEO | BUY | $7.71 | 6,500 | $50,115 | 213,620 | +3.1% |
| 2017-08-11 16:04 | 2017-08-10 | Coughlin Terrance J | Officer - EVP, Chief Operating Officer | BUY | $7.70 | 20,000 | $154,000 | 140,582 | +16.6% |
| 2017-03-17 00:54 | 2017-03-16 | Campanelli Paul | Director, Officer - President, CEO | BUY | $10.72 | 2,300 | $24,656 | 207,120 | +1.1% |
| 2017-03-10 18:24 | 2017-03-09 | Hutson Nancy J | Director | SELL | $10.82 | 5,325 | $57,617 | 31,252 | -14.6% |
| 2016-11-16 22:00 | 2016-11-15 | KIMMEL ROGER H | Director | SELL | $17.38 | 14,000 | $243,264 | 188,000 | -6.9% |
| 2016-05-18 23:28 | 2016-05-05 | INGRAM DOUGLAS S | Director | SELL | $26.59 | 4,513 | $120,001 | 4,890 | -48.0% |
| 2016-05-12 20:08 | 2016-05-11 | HIGGINS ARTHUR J | Director | BUY | $13.80 | 5,000 | $69,000 | 50,623 | +11.0% |
| 2016-05-11 21:20 | 2016-05-10 | Campanelli Paul | Officer - Group President, Generics | BUY | $15.53 | 13,000 | $201,890 | 201,069 | +6.9% |
| 2016-05-11 21:22 | 2016-05-10 | HIGGINS ARTHUR J | Director | BUY | $15.42 | 11,000 | $169,620 | 45,623 | +31.8% |
| 2016-05-11 21:26 | 2016-05-10 | KIMMEL ROGER H | Director | BUY | $15.53 | 7,000 | $108,720 | 195,000 | +3.7% |
| 2016-04-22 00:07 | 2016-03-01 | MONTAGUE WILLIAM P | Director | SELL | $42.19 | 3,413 | $143,994 | 39,228 | -8.0% |
| 2016-03-18 02:03 | 2016-03-17 | Spengler William | Director | BUY | $29.20 | 1,000 | $29,200 | 48,835 | +2.1% |
| 2016-03-16 20:36 | 2016-03-16 | Spengler William | Director | BUY | $35.24 | 1,000 | $35,240 | 47,835 | +2.1% |
| 2016-03-14 22:07 | 2016-03-14 | KIMMEL ROGER H | Director | BUY | $41.94 | 1,125 | $47,183 | 73,362 | +1.6% |
| 2016-03-07 23:58 | 2016-03-07 | Maletta Matthew Joseph | Officer - Exec. V.P.,Chief Legal Officer | BUY | $44.48 | 500 | $22,240 | 1,000 | +100.0% |
| 2016-03-07 23:57 | 2016-03-07 | DE SILVA RAJIV | Director, Officer - President & CEO | BUY | $44.50 | 2,250 | $100,125 | 250,705 | +0.9% |
| 2016-03-04 04:57 | 2016-03-01 | Smith Jill D. | Director | SELL | $42.19 | 3,413 | $143,994 | 19,785 | -14.7% |
| 2016-03-04 04:53 | 2016-03-01 | Hutson Nancy J | Director | SELL | $42.19 | 3,413 | $143,994 | 36,577 | -8.5% |
| 2016-03-04 04:58 | 2016-03-01 | Spengler William | Director | SELL | $42.19 | 3,413 | $143,994 | 46,835 | -6.8% |
| 2016-03-04 04:55 | 2016-03-01 | HYATT MICHAEL | Director | SELL | $42.19 | 3,413 | $143,994 | 250,297 | -1.3% |
| 2015-11-17 18:40 | 2015-11-16 | KIMMEL ROGER H | Director | BUY | $57.00 | 841 | $47,937 | 108,362 | +0.8% |
| 2015-11-12 15:38 | 2015-11-11 | Maletta Matthew Joseph | Officer - Exec. V.P.,Chief Legal Officer | BUY | $56.19 | 500 | $28,095 | 500 | +100.0% |
| 2015-11-12 15:37 | 2015-11-11 | Lortie Brian | Officer - President Branded Pharma | BUY | $56.47 | 700 | $39,529 | 17,484 | +4.2% |
| 2015-11-12 15:36 | 2015-11-11 | Hall Susan | Officer - EVP, CSO, Global Head of R&D | BUY | $55.35 | 1,000 | $55,350 | 2,666 | +60.0% |
| 2015-11-12 15:35 | 2015-11-11 | Upadhyay Suketu | Officer - EVP, Chief Financial Officer | BUY | $56.37 | 4,450 | $250,856 | 15,886 | +38.9% |
| 2015-11-13 01:36 | 2015-11-12 | Cooke Shane | Director | BUY | $57.13 | 4,000 | $228,520 | 10,179 | +64.7% |
| 2015-11-12 15:33 | 2015-11-11 | DE SILVA RAJIV | Director, Officer - President & CEO | BUY | $55.52 | 9,006 | $500,013 | 181,380 | +5.2% |
| 2015-11-12 15:35 | 2015-11-11 | Campanelli Paul | Officer - President, Par Pharmaceutical | BUY | $55.69 | 2,100 | $116,954 | 188,069 | +1.1% |
| 2015-11-12 15:37 | 2015-11-11 | HYATT MICHAEL | Director | OPT+S | $55.48 | 8,000 | $443,840 | 251,599 | 0.0% |
| 2015-06-18 23:44 | 2015-06-16 | HIGGINS ARTHUR J | Director | BUY | $81.10 | 2,500 | $202,750 | 22,771 | +12.3% |
| 2015-04-10 00:16 | 2015-04-07 | MANOGUE CAROLINE B | Officer - Exec. V.P.,Chief Legal Officer | OPT+S | $91.90 | 105,562 | $9,701,148 | 43,100 | 0.0% |
| 2015-03-13 00:25 | 2015-03-10 | Farhat Camille | Officer - President, AMS, Inc. | SELL | $89.39 | 8,650 | $773,224 | 0 | -100.0% |
| 2015-03-11 23:39 | 2015-03-09 | Farhat Camille | Officer - President, AMS, Inc. | OPT+S | $87.02 | 40,438 | $3,518,915 | 8,650 | 0.0% |
| 2015-03-09 23:51 | 2015-03-05 | MANOGUE CAROLINE B | Officer - Exec. V.P.,Chief Legal Officer | OPT+S | $87.78 | 42,033 | $3,689,657 | 43,100 | 0.0% |
| 2015-03-07 00:56 | 2015-03-04 | Lortie Brian | Officer - President Branded Pharma | SELL | $85.35 | 5,800 | $495,030 | 16,784 | -25.7% |
| 2014-11-19 00:55 | 2014-11-14 | Upadhyay Suketu | Officer - EVP, Chief Financial Officer | BUY | $66.94 | 3,700 | $247,678 | 7,222 | +105.1% |
| 2014-08-08 00:15 | 2014-08-05 | HIGGINS ARTHUR J | Director | BUY | $65.65 | 3,500 | $229,775 | 8,827 | +65.7% |
| 2014-03-12 03:19 | 2014-03-10 | Hutson Nancy J | Director | OPT+S | $72.12 | 5,000 | $360,600 | 20,483 | 0.0% |
| 2014-03-12 03:18 | 2014-03-10 | Gergel Ivan P. | Officer - EVP, R&D and CSO | OPT+S | $72.47 | 75,637 | $5,481,413 | 27,649 | 0.0% |
| 2014-03-12 03:18 | 2014-03-10 | HIGGINS ARTHUR J | Director | BUY | $73.00 | 5,000 | $365,000 | 5,000 | +100.0% |
How to Interpret $ENDP Trades
Not every insider transaction in ENDP is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $ENDP shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for ENDP
Insider activity data for ENDP is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $ENDP, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.